Sangeet Adhikari

Dr. Sangeet Adhikari

Arizona State University
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Polymer International
Verified
Journal Article
Open access
PDF file
Sangeet AdhikariSangeet Adhikari
Sangeet Adhikari
VKVarun Kelkar
Varun Kelkar
RKRahul Kumar
Rahul Kumar
RHRolf Halden
Rolf Halden
Microplastics (MPs) and nanoplastics (NPs) constitute a newly recognized class of contaminants of emerging concern in air, soil, water and food, causing unavoidable exposure to humans and animals. Detection, identification and quantification of MPs and NPs in environmental matrices and biota is challenging due to the analytes' small size, random morphology, polymeric diversity, applied coatings and vast surface areas which attract chemical and microbial sorbates. This mini‐review explores strengths and weaknesses of analytical methods commonly used for MP and NP identification and quantification, including stereomicroscopy, SEM, Fourier transform infrared spectroscopy, Raman spectroscopy, flow cytometry and mass spectrometry techniques including matrix‐assisted laser desorption/ionization time‐of‐flight, pyrolysis gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry. Analytical challenges involved in precise MP/NP detection have been identified and recommendations have been provided to ensure data quality addressing common data quality concerns, including the difficulty of obtaining irrefutable proof that detected polymers originated from the sample as opposed to sample contamination during sample acquisition, sample processing and analysis. © 2021 The Authors. Polymer International published by John Wiley & Sons Ltd on behalf of Society of Industrial Chemistry.

1 October 2021 in Water Research
Verified
Journal Article
Open access
RFRafaela Salgado Fontenele
Rafaela Salgado Fontenele
SKSimona Kraberger
Simona Kraberger
JHJames Hadfield
James Hadfield
EDErin Driver
Erin Driver
Devin A BowesDevin A Bowes
Devin A Bowes
Arvind VarsaniArvind Varsani
Arvind Varsani
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely emerged from a zoonotic spill-over event and has led to a global pandemic. The public health response has been predominantly informed by surveillance of symptomatic individuals and contact tracing, with quarantine, and other preventive measures have then been applied to mitigate further spread. Non-traditional methods of surveillance such as genomic epidemiology and wastewater-based epidemiology (WBE) have also been leveraged during this pandemic. Genomic epidemiology uses high-throughput sequencing of SARS-CoV-2 genomes to inform local and international transmission events, as well as the diversity of circulating variants. WBE uses wastewater to analyse community spread, as it is known that SARS-CoV-2 is shed through bodily excretions. Since both symptomatic and asymptomatic individuals contribute to wastewater inputs, we hypothesized that the resultant pooled sample of population-wide excreta can provide a more comprehensive picture of SARS-CoV-2 genomic diversity circulating in a community than clinical testing and sequencing alone. In this study, we analysed 91 wastewater samples from 11 states in the USA, where the majority of samples represent Maricopa County, Arizona (USA). With the objective of assessing the viral diversity at a population scale, we undertook a single-nucleotide variant (SNV) analysis on data from 52 samples with >90% SARS-CoV-2 genome coverage of sequence reads, and compared these SNVs with those detected in genomes sequenced from clinical patients. We identified 7973 SNVs, of which 548 were “novel” SNVs that had not yet been identified in the global clinical-derived data as of 17th June 2020 (the day after our last wastewater sampling date). However, between 17th of June 2020 and 20th November 2020, almost half of the novel SNVs have since been detected in clinical-derived data. Using the combination of SNVs present in each sample, we identified the more probable lineages present in that sample and compared them to lineages observed in North America prior to our sampling dates. The wastewater-derived SARS-CoV-2 sequence data indicates there were more lineages circulating across the sampled communities than represented in the clinical-derived data. Principal coordinate analyses identified patterns in population structure based on genetic variation within the sequenced samples, with clear trends associated with increased diversity likely due to a higher number of infected individuals relative to the sampling dates. We demonstrate that genetic correlation analysis combined with SNVs analysis using wastewater sampling can provide a comprehensive snapshot of the SARS-CoV-2 genetic population structure circulating within a community, which might not be observed if relying solely on clinical cases.



7 March 2023 in Water
Verified
Journal Article
Open access
PDF file
Ananda TiwariAnanda Tiwari
Ananda Tiwari
Sangeet AdhikariSangeet Adhikari
Sangeet Adhikari
SZShuxin Zhang
Shuxin Zhang
TSTamunobelema B. Solomon
Tamunobelema B. Solomon
ALAnssi Lipponen
Anssi Lipponen
Samendra SherchanSamendra Sherchan
Samendra Sherchan
The emergence of new variants of SARS-CoV-2 associated with varying infectivity, pathogenicity, diagnosis, and effectiveness against treatments challenged the overall management of the COVID-19 pandemic. Wastewater surveillance (WWS), i.e., monitoring COVID-19 infections in communities through detecting viruses in wastewater, was applied to track the emergence and spread of SARS-CoV-2 variants globally. However, there is a lack of comprehensive understanding of the use and effectiveness of WWS for new SARS-CoV-2 variants. Here we systematically reviewed published articles reporting monitoring of different SARS-CoV-2 variants in wastewater by following the PRISMA guidelines and provided the current state of the art of this study area. A total of 80 WWS studies were found that reported different monitoring variants of SARS-CoV-2 until November 2022. Most of these studies (66 out of the total 80, 82.5%) were conducted in Europe and North America, i.e., resource-rich countries. There was a high variation in WWS sampling strategy around the world, with composite sampling (50/66 total studies, 76%) as the primary method in resource-rich countries. In contrast, grab sampling was more common (8/14 total studies, 57%) in resource-limited countries. Among detection methods, the reverse transcriptase polymerase chain reaction (RT-PCR)-based sequencing method and quantitative RT-PCR method were commonly used for monitoring SARS-CoV-2 variants in wastewater. Among different variants, the B1.1.7 (Alpha) variant that appeared earlier in the pandemic was the most reported (48/80 total studies), followed by B.1.617.2 (Delta), B.1.351 (Beta), P.1 (Gamma), and others in wastewater. All variants reported in WWS studies followed the same pattern as the clinical reporting within the same timeline, demonstrating that WWS tracked all variants in a timely way when the variants emerged. Thus, wastewater monitoring may be utilized to identify the presence or absence of SARS-CoV-2 and follow the development and transmission of existing and emerging variants. Routine wastewater monitoring is a powerful infectious disease surveillance tool when implemented globally.

23 August 2023 in Environmental Science & Technology
Verified
Journal Article
Open access
Devin A BowesDevin A Bowes
Devin A Bowes
ADAmanda Darling
Amanda Darling
EDErin Driver
Erin Driver
DKDevrim Kaya
Devrim Kaya
RMRasha Maal-Bared
Rasha Maal-Bared
CMCresten Mansfeldt
Cresten Mansfeldt
Wastewater-based testing (WBT) for SARS-CoV-2 has rapidly expanded over the past three years due to its ability to provide a comprehensive measurement of disease prevalence independent of clinical testing. The development and simultaneous application of WBT measured biomarkers for research activities and for the pursuit of public health goals, both areas with well-established ethical frameworks. Currently, WBT practitioners do not employ a standardized ethical review process, introducing the potential for adverse outcomes for WBT professionals and community members. To address this deficiency, an interdisciplinary workshop developed a framework for a structured ethical review of WBT. The workshop employed a consensus approach to create this framework as a set of 11 questions derived from primarily public health guidance. This study retrospectively applied these questions to SARS-CoV-2 monitoring programs covering the emergent phase of the pandemic (3/2020-2/2022 (n = 53)). Of note, 43% of answers highlight a lack of reported information to assess. Therefore, a systematic framework would at a minimum structure the communication of ethical considerations for applications of WBT. Consistent application of an ethical review will also assist in developing a practice of updating approaches and techniques to reflect the concerns held by both those practicing and those being monitored by WBT supported programs.